Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
03 August 2012Website:
http://www.globusmedical.comNext earnings report:
05 November 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 01 Nov 2024 22:17:45 GMTDividend
Analysts recommendations
Institutional Ownership
GMED Latest News
LOS ANGELES, CA / ACCESSWIRE / November 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or "the Company") (NYSE:GMED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
LOS ANGELES, CA / ACCESSWIRE / November 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or "the Company") (NYSE:GMED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Beyond analysts' top -and-bottom-line estimates for Globus Medical (GMED), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2024.
LOS ANGELES, CA / ACCESSWIRE / October 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or "the Company") (NYSE:GMED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
LOS ANGELES, CA / ACCESSWIRE / October 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or "the Company") (NYSE:GMED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
LOS ANGELES, CA / ACCESSWIRE / October 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or "the Company") (NYSE:GMED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
LOS ANGELES, CA / ACCESSWIRE / October 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or "the Company") (NYSE:GMED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
AUDUBON, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, is participating in the 40th Annual Meeting of the Orthopedic Trauma Association (OTA) in Montréal, Canada, October 23—26.
AUDUBON, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2024 after the market close on Tuesday, November 5, 2024. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com.
LOS ANGELES, CA / ACCESSWIRE / October 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or "the Company") (NYSE:GMED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
What type of business is Globus Medical?
Globus Medical, Inc. is a technology company headquartered in Audubon, Pennsylvania, specializing in the development, manufacturing, and distribution of medical devices for the treatment and restoration of the musculoskeletal system of patients. It was founded in 2003. All products of Globus Medical can be divided into two groups: Musculoskeletal solutions - mainly consist of implants, biomaterials, devices, and surgical instruments used in spinal fusion procedures, orthopedic, and neurosurgical procedures (RISE, RISE-L, CALIBER, CALIBER -L, ALTERA, ELSA, ELSA-ATP, SABLE, MAGNIFY, MAGNIFY-S, FORTIFY, XPand, QUARTEX, KINEX, AFFIRM, etc.). Supporting technologies - consist of surgical robotic solutions (ExcelsiusGPS, Surgimap).
What sector is Globus Medical in?
Globus Medical is in the Healthcare sector
What industry is Globus Medical in?
Globus Medical is in the Medical Devices industry
What country is Globus Medical from?
Globus Medical is headquartered in United States
When did Globus Medical go public?
Globus Medical initial public offering (IPO) was on 03 August 2012
What is Globus Medical website?
https://www.globusmedical.com
Is Globus Medical in the S&P 500?
No, Globus Medical is not included in the S&P 500 index
Is Globus Medical in the NASDAQ 100?
No, Globus Medical is not included in the NASDAQ 100 index
Is Globus Medical in the Dow Jones?
No, Globus Medical is not included in the Dow Jones index
When was Globus Medical the previous earnings report?
No data
When does Globus Medical earnings report?
The next expected earnings date for Globus Medical is 05 November 2024